HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TLR4/AP-1-Targeted Anti-Inflammatory Intervention Attenuates Insulin Sensitivity and Liver Steatosis.

Abstract
Insulin resistance has been shown to be the common pathogenesis of many metabolic diseases. Metainflammation is one of the important characteristics of insulin resistance. Macrophage polarization mediates the production and development of metainflammation. Toll-like receptor 4 (TLR4) mediates macrophage activity and is probably the intersection of immunity and metabolism, but the detailed mechanism is probably not fully understood. Activated protein 1 (AP1) signaling pathway is very important in macrophage activation-mediated inflammation. However, it is unclear whether AP1 signaling pathway mediates metabolic inflammation in the liver. We aimed to investigate the effects of macrophage TLR4-AP1 signaling pathway on hepatocyte metabolic inflammation, insulin sensitivity, and lipid deposition, as well as to explore the potential of TLR4-AP1 as new intervention targets of insulin resistance and liver steatosis. TLR4 and AP1 were silenced in the RAW264.7 cells by lentiviral siRNA transfection. In vivo transduction of lentivirus was administered in mice fed with high-fat diet. Insulin sensitivity and inflammation were evaluated in the treated cells or animals. Our results indicated that TLR4/AP-1 siRNA transfection alleviated high-fat diet-induced systemic and hepatic inflammation, obesity, and insulin resistance in mice. Additionally, TLR4/AP-1 siRNA transfection mitigated palmitic acid- (PA-) induced inflammation in RAW264.7 cells and metabolic abnormalities in cocultured AML hepatocytes. Herein, we propose that TLR4-AP1 signaling pathway activation plays a crucial role in high fat- or PA-induced metabolic inflammation and insulin resistance in hepatocytes. Intervention of the TLR4 expression regulates macrophage polarization and metabolic inflammation and further alleviates insulin resistance and lipid deposition in hepatocytes.
AuthorsXiang Hu, Jing Zhou, Sha-Sha Song, Wen Kong, Yan-Chuan Shi, Lu-Lu Chen, Tian-Shu Zeng
JournalMediators of inflammation (Mediators Inflamm) Vol. 2020 Pg. 2960517 ( 2020) ISSN: 1466-1861 [Electronic] United States
PMID33013197 (Publication Type: Journal Article)
CopyrightCopyright © 2020 Xiang Hu et al.
Chemical References
  • Fatty Acids, Nonesterified
  • Insulin
  • Interleukin-1beta
  • Interleukin-6
  • RNA, Small Interfering
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4
  • Triglycerides
  • Tumor Necrosis Factor-alpha
  • Interleukin-10
  • Cholesterol
Topics
  • Animals
  • Blotting, Western
  • Cholesterol (blood)
  • Enzyme-Linked Immunosorbent Assay
  • Fatty Acids, Nonesterified (blood)
  • Fatty Liver (blood)
  • Glucose Tolerance Test
  • Inflammation (blood)
  • Insulin (blood)
  • Interleukin-10 (blood)
  • Interleukin-1beta (blood)
  • Interleukin-6 (blood)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • RAW 264.7 Cells
  • RNA, Small Interfering (genetics, metabolism)
  • Real-Time Polymerase Chain Reaction
  • Toll-Like Receptor 4 (blood)
  • Triglycerides (blood)
  • Tumor Necrosis Factor-alpha (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: